Lymph Node Follicle‐Targeting STING Agonist Nanoshells Enable Single‐Shot M2e Vaccination for Broad and Durable Influenza Protection
Advanced Science · 2023-06 · 10 (17)
DOI: 10.1002/advs.202206521 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 24.04.2023. Verfasst von Hsiao-Han Tsai und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biomedical Sciences, Academia Sinica, Taipei, 115, Taiwan. Hauptthemen laut MEDLINE: Influenza, Human, Nanoshells, Influenza Vaccines. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Council, Taiwan, Academia Sinica Career Development Award.
Abstract (Originalsprache)
The highly conserved matrix protein 2 ectodomain (M2e) of influenza viruses presents a compelling vaccine antigen candidate for stemming the pandemic threat of the mutation‐prone pathogen, yet the low immunogenicity of the diminutive M2e peptide renders vaccine development challenging. A highly potent M2e nanoshell vaccine that confers broad and durable influenza protectivity under a single vaccination is shown. Prepared via asymmetric ionic stabilization for nanoscopic curvature formation, polymeric nanoshells co‐encapsulating high densities of M2e peptides and stimulator of interferon genes (STING) agonists are prepared. Robust and long‐lasting protectivity against heterotypic influenza viruses is achieved with a single administration of the M2e nanoshells in mice. Mechanistically, molecular adjuvancy by the STING agonist and nanoshell‐mediated prolongation of M2e antigen exposure in the lymph node follicles synergistically contribute to the heightened anti‐M2e humoral responses. STING agonist‐triggered T cell helper functions and extended residence of M2e peptides in the follicular dendritic cell network provide a favorable microenvironment that induces Th1‐biased antibody production against the diminutive antigen. These findings highlight a versatile nanoparticulate design that leverages innate immune pathways for enhancing the immunogenicity of weak immunogens. The single‐shot nanovaccine further provides a translationally viable platform for pandemic preparedness.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Biomedical Sciences, Academia Sinica, Taipei, 115, Taiwan.
- Taiwan International Graduate Program in Molecular Medicine, National Yang Ming Chiao Tung University and Academia Sinica, Taipei, 112, Taiwan.
- Department of Veterinary Medicine, National Taiwan University, Taipei, 10617, Taiwan.
- Biomedical Translation Research Center, Academia Sinica, Taipei, 115, Taiwan.
- Center of Applied Nanomedicine, National Cheng Kung University, Tainan, 70101, Taiwan.
ORCID-Profile: Che-Ming J Hu
Förderung
- National Science and Technology Council, Taiwan
- Academia Sinica Career Development Award
Zitieren
APA
Tsai, H. H., Huang, P. H., Lin, L. C., Yao, B. Y., Liao, W. T., Pai, C. H., Liu, Y. H., Chen, H. W., & Hu, C. J. (2023). Lymph Node Follicle‐Targeting STING Agonist Nanoshells Enable Single‐Shot M2e Vaccination for Broad and Durable Influenza Protection. Advanced Science, 10(17). https://doi.org/10.1002/advs.202206521
Vancouver
Tsai HH, Huang PH, Lin LC, Yao BY, Liao WT, Pai CH, et al. Lymph Node Follicle‐Targeting STING Agonist Nanoshells Enable Single‐Shot M2e Vaccination for Broad and Durable Influenza Protection. Advanced Science. 2023;10(17). doi:10.1002/advs.202206521
BibTeX
@article{Tsai2023,
author = {Tsai, Hsiao-Han and Huang, Ping-Han and Lin, Leon Cw and Yao, Bing-Yu and Liao, Wan-Ting and Pai, Chen-Hsueh and Liu, Yu-Han and Chen, Hui-Wen and Hu, Che-Ming J},
title = {Lymph Node Follicle‐Targeting STING Agonist Nanoshells Enable Single‐Shot M2e Vaccination for Broad and Durable Influenza Protection},
journal = {Advanced Science},
year = {2023},
volume = {10},
number = {17},
doi = {10.1002/advs.202206521}
}
EUVIMED